share_log
Reuters ·  May 9 08:11
Seres Therapeutics : Oppenheimer Cuts Target Price to $4 From $5
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment